We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
| Share Name | Share Symbol | Market | Stock Type |
|---|---|---|---|
| Greenhouse | GHF | London | Ordinary Share |
| Price Change | Price Change % | Share Price | Last Trade
|
|
|---|---|---|---|---|
| 0.00 | 0.00% | 6.625 | 01:00:00 |
| Open Price | Low Price | High Price | Close Price | Previous Close |
|---|---|---|---|---|
| 6.625 |
| Top Posts |
|---|
Posted at 16/7/2008 15:53 by reckless_rat a tidying up job. Molectra tried and failed to raise new funding in its own right last winter and seemingly again more recently. GHF were left with little option but to take full control or face writing off their investment. Going to be a long slog from here, with all eggs in one basket. |
Posted at 23/3/2008 05:04 by steve3005 No that's not the reason, the products from the recycling have been flagged very clearly and will never be anything other than mundane stuff - but the market is crying out for the main products (steel, crumb rubber). And as pointed out in my post GHF I think will be on a p/e of just 7 later this year, and is now trading on less than nav? |
Posted at 25/2/2008 09:22 by steve3005 Here are my jottings on the GHF. As usual DYO research, this isn't a recommendation to invest etc. Disclosure - I hold shares in GHF and in Virotec. There is little news flow (even the 2007 interims aren't on the website) The shares are v tightly held 10 holders account for 75%, 28 holders account for 98% so maybe that's why there is no news word of mouth will suffice! Virotec holds 19.3% - no sell off of this holding, they hit Hydrodec instead for some more cash. Notable investors include David Gaskell the funds investment advisor (10%), Nigel Wray (resigned as a director but didn't sell off his shareholding of 7.5m shares). I'm puzzled by the comment that 66.3m shares (42%) not in public hands being held by insiders? Fund is trading at close to its NAV, probably due to lack of news flow. IMHO a downside is that Brian Sheeran is Chairman now Wray has gone the only thing Brian has done as far as I can tell (IMHO) in Virotec is draw down a huge salary while destroying shareholder value. Please let me know if I'm wrong here and I will apologise effusively for my comment. The good thing is the Board of the fund is capped in how much they can charge, so no massive cheques for no ascertainable value a la Virotec. Elsiva invested in 10m shares in 9/07 What's the company done? 1. Invested in Molectra it now hold 58% of company. Also advanced a loan of AU$4.5m to secure land for building full plant. (No news on progress can be found). There is a massive worldwide problem with used tyres, Molectra technology recovers 100% of tyre, and even uses some of the by products to power the plant! Proven technology in pilot plant. Currently consumers pay levy to dispose of tyres so raw materials will be free if not an additional flow of cash. Molectra reckons on getting AU$5.40 (£2.50) value per tyre, not clear if this is gross or net - it comes from a comment from the inventor of the process. Greenhouse says the Wiley report (can't find this published anywhere) suggests for the new large scale process plant: Capex = £6m Process costs: 2.6m tyres (26,000 tons @£70/ton) = £1,8m Income (from Molectra comment) = (2.6m*£2.50) = £6.5m Gross profit = 4.7m Less capex writedown expenses etc say £1m Net = 3.7m Greenhouse entitled to 58%, so with 155m shares that = 1.38pps. So at 10p a share for GHF = P/E of 7 just from initial stage of Molectra Rights to Molectra technology have been sold to 19 countries - not sure on what terms. 2. Invested £570k plus GHF shares (hence 19% shareholding by Virotec) in non-core Bauxol technology from Virotech, carrying this investment at £6m in balance sheet. Very quiet on development progress. Maybe something will be announced in annual accounts? Last accounts: Assets = £13m Shares = 155m NAV = 8.4pps Share price this morning 8.6p Interesting company! |
Posted at 15/5/2007 12:58 by clusium Assuming spinning out the Milectra business makes a whole lot for GHF, is this the crucially advantageous time to buy? Or is having some Virotec, with its c19% holding and other activities enough? |
Posted at 06/5/2007 21:10 by edale Looking at the preliminary report there are only 74 shareholders in GHF. I would have thought an unusually small number. Are we the wise few or the foolish few ? With such a small number of investors presumably this means the shares are tightly held and any positive change in sentiment could lead to a rapid increase in share price.I guess only time will tell although Molectra does look to have great potential. |
Posted at 07/1/2007 22:44 by edale I keep looking for an update on the performance of the scaled up Molectra plant trials which I believe should be available sometime in the first quarter. This looks very interesting technology and successful plant trials leading to take up of plants round the world would be a major boost for GHF although I guess could short term call up more capital. |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
